Antibody Response and Variant Cross-Neutralization After SARS-CoV-2 Breakthrough Infection-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Antibody Response and Variant Cross-Neutralization After SARS-CoV-2 Breakthrough Infection

Published:2021-12-16 Issue: Volume: Page:
ISSN:0098-7484
Container-title:JAMA
language:en
Short-container-title:JAMA

Author:

Bates Timothy A.¹,McBride Savannah K.¹,Winders Bradie²,Schoen Devin²,Trautmann Lydie³,Curlin Marcel E.²,Tafesse Fikadu G.¹

Affiliation:

1. Department of Molecular Microbiology & Immunology, Oregon Health & Science University, Portland

2. Division of Infectious Diseases, Oregon Health & Science University, Portland

3. Vaccine and Gene Therapy Institute, Oregon Health & Science University, Portland

Publisher

American Medical Association (AMA)

Subject

General Medicine

Link

https://jamanetwork.com/journals/jama/articlepdf/2787447/jama_bates_2021_ld_210083_1639607673.6492.pdf

Reference6 articles.

1. Waning immune humoral response to BNT162b2 Covid-19 vaccine over 6 months.;Levin;N Engl J Med,2021

2. Resistance of SARS-CoV-2 variants to neutralization by monoclonal and serum-derived polyclonal antibodies.;Chen;Nat Med,2021

3. Effectiveness of Covid-19 vaccines against the B.1.617.2 (Delta) variant.;Lopez Bernal;N Engl J Med,2021

4. Covid-19 breakthrough infections in vaccinated health care workers.;Bergwerk;N Engl J Med,2021

5. An observational study of breakthrough SARS-CoV-2 Delta variant infections among vaccinated healthcare workers in Vietnam.;Chau;EClinicalMedicine,2021

Cited by 95 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A single-dose intranasal live-attenuated codon deoptimized vaccine provides broad protection against SARS-CoV-2 and its variants;Nature Communications;2024-08-26

2. T cell hybrid immunity against SARS-CoV-2 in children: a longitudinal study;eBioMedicine;2024-07

3. COVID-19 Vaccines Breakthrough Infections and Adverse Effects Reported by the Birzeit University Community in Palestine;International Journal of General Medicine;2024-07

4. Kinetics and Durability of Antibody and T-Cell Responses to SARS-CoV-2 in Children;The Journal of Infectious Diseases;2024-06-05

5. Validation and Suitability Assessment of Multiplex Mesoscale Discovery Immunogenicity Assay for Establishing Serological Signatures Using Vaccinated, Non-Vaccinated and Breakthrough SARS-CoV-2 Infected Cases;Vaccines;2024-04-18

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3